Treating a recurrent uterine arteriovenous malformation with uterine artery embolization. A case report.

Departments of Obstetrics and Gynaecology and of Diagnostic Radiology, Queen Mary Hospital, University of Hong Kong, 102 Pokfulam Road, Hong Kong SAR, China.
The Journal of reproductive medicine (Impact Factor: 0.7). 12/2003; 48(11):905-7.
Source: PubMed

ABSTRACT Uterine arteriovenous malformation is a rare condition. Uterine artery embolization offers the possibility of conservative management as opposed to the traditional hysterectomy. We report a case with recurrent uterine arteriovenous malformation confirmed by angiography and successfully treated with a second embolization procedure.
A 33-year-old woman presented with heavy vaginal bleeding. The diagnosis of uterine arteriovenous malformation was suspected on Doppler ultrasonography and confirmed by angiography. The first embolization procedure was performed using polyvinyl alcohol and steel coils. Recurrence was diagnosed 1 year later with the same imaging techniques. The second embolization procedure was performed using histoacryl. The patient remained asymptomatic at 1-year of follow-up.
Minimally invasive management is an option in recurrent uterine arteriovenous malformation.

61 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: Uterine arteriovenous malformation is a rare condition. We report a case with acquired arteriovenous malformation arising from the left uterine artery. She was diagnosed by color Doppler ultrasound and treated with a selective uterine artery embolization.
    Gynécologie Obstétrique & Fertilité 07/2005; 33(7-8):511-3. DOI:10.1016/j.gyobfe.2005.05.018 · 0.52 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Uterine artery embolization (UAE) is a relatively new alternative treatment for symptomatic fibroids. Recent Level 1 evidence from two major randomized controlled trials has established UAE as a safe and effective alternative to hysterectomy. Technical aspects, choice of embolic agent, safety, contra-indications and complications of the procedure will be reviewed. The available data on the effects on ovarian function, fertility and pregnancy outcomes following UAE will be presented.
    Bailli&egrave re s Best Practice and Research in Clinical Obstetrics and Gynaecology 09/2008; 22(4):717-34. DOI:10.1016/j.bpobgyn.2008.01.013 · 1.92 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: A 19-year-old patient presented with intractable uterine bleeding, 11weeks post-abortion. A pelvic ultrasound with Doppler and color imaging suggested a uterine arteriovenous malformation. Failing conservative therapies, the patient consented to uterine artery embolization (UAE). Two months later, she conceived and had an uneventful normal vaginal delivery at term. Since this is an extremely rare condition, allowing limited clinical exposure and experience, there may be an underlying reluctance by general practitioners to treat these cases with uterine artery embolization for fear of compromising future fertility and pregnancies. However, data from the 20 pregnancies embolized for uterine AVM cited in the present report and data from embolization for uterine fibroids indicate that such fears may be unfounded since pregnancy rates and outcomes may not be compromised after UAE. KeywordsMenorrhagia-Arteriovenous malformation-Uterine artery embolization-Pregnancy
    Gynecological Surgery 11/2010; 7(4):401-405. DOI:10.1007/s10397-009-0503-5
Show more